InvestorsHub Logo
Followers 3
Posts 3535
Boards Moderated 0
Alias Born 06/15/2005

Re: Gold Seeker post# 16562

Saturday, 10/04/2008 11:02:41 PM

Saturday, October 04, 2008 11:02:41 PM

Post# of 30387
Gold,

That was done. "Publish hard data with good results on stage one and two cancer patients and I will take notice"

Following the report that early stage cancers were picked up you switched to your comments that it can't be justified because of small amounts of possible prostate cancer in the test samples.

Gold your circle of negatives are catching up to you.

I am sorry to say, To this point nothing suffices for you.

The results of this study showed that 80.4% of ovarian cancers (Stages I-III) were detected with 88% specificity. The samples included 64 normal controls, 51 serum samples from patients with ovarian cancer [25 samples at Stage I and II (b-c) and 26 samples at Stage III (b-c)]. The device used in the research was similar to the common pregnancy test kit and represents a potential breakthrough of great magnitude in simplifying cancer detection.

These results show that a rapid lateral flow chromatography test based on the RECAFTM marker can discriminate well between cancer and normal samples. When applied to the examples of early-stage ovarian cancer, the rapid test demonstrated better performance than CA-125.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.